自体主导多囊性病的治疗方法:超出托尔瓦普坦的范围
Christina Fang1, Sayna Norouzi2, Pranav S Garimella3
1Department of Medicine, UC San Diego, San Diego, California.
Current opinion in nephrology and hypertension
|July 29, 2025
概括
自体主导性多囊性病 (ADPKD) 的新兴疗法在减缓囊生长和保持功能方面表现有前途. 这些包括新的药物,饮食改变和基因治疗,提供了超越当前选择的希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 自体主导多囊性病 (ADPKD) 是一种遗传性疾病,导致囊,扩大和衰竭.
- 托尔瓦普坦是FDA批准的ADPKD治疗的唯一疗法,这凸显了对新疗法的需求.
- 疾病的进展涉及复杂的机制,如细胞生成和代谢变化.
研究的目的:
- 审查ADPKD的新兴治疗干预措施.
- 探索针对囊发生,代谢重编程和功能下降的新策略.
- 讨论目前在临床前和临床开发中的ADPKD治疗方法的管道.
主要方法:
- 最近的临床前和早期临床研究的文献综述.
- 分析新兴的药理学药剂,饮食干预和基因疗法.
- 讨论正在进行的ADPKD治疗的2期和3期临床试验.
主要成果:
- 有前途的治疗候选药物包括AMPK激活剂 (甲福明),SGLT2抑制剂,GLP-1受体激动剂和bempedoic酸.
- 饮食干预措施,如性饮食和热量限制,显示出减少囊负担的潜力.
- 基于RNA的疗法 (miR-17) 和PC1校正剂 (VX-407) 代表了有针对性的遗传方法.
结论:
- ADPKD的治疗环境正在迅速发展,有多种创新疗法.
- 综合药理,饮食和遗传策略的综合方法至关重要.
- 需要进行大规模的长期研究来验证疗效并优化个性化护理.
更多相关视频
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
9.9K
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
17.8K
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
01:20Acute Kidney Injury V: Interprofessional Care
45
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
45
01:28Renal Drug Excretion: Tubular Secretion
363
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
363
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
773
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
773
01:26Nephrotic Syndrome II : Assessment and Medical Management
23
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
23